Switzerland very close to tariff deal with the US, says Roche CEO
This content was published on
An understanding between Berne and Washington in the dispute over customs barriers is close: Roche CEO Thomas Schinecker is convinced of this.
Potential US tariff exemption for Swiss pharma is not necessarily a boon
This content was published on
Donald Trump is pressuring the pharma industry with tariffs. But experts say that tariffs will have less impact on the industry than pricing.
How US tariffs could disrupt the generic drugs supply chain
This content was published on
US tariffs on generics could raise drug prices and accentuate shortages. That's not what US President Donald Trump had in mind.
Sandoz board chair ‘convinced that common sense will ultimately prevail’ on US pharma tariffs
This content was published on
In an exclusive interview with Swissinfo, Sandoz chair Gilbert Ghostine says he remains optimistic despite looming tariff hikes.
Has your continent reached its peak or is there still potential for economic growth?
Some regions of the world are on an upward trajectory with the promise of a steadily improving future. Where do you live? And in which direction is your region or continent developing?
